Strategic Evolution in Pathology: Understanding Modern Diagnostic Drivers
The integration of advanced molecular tools into clinical practice has redefined the standards of tissue-based diagnostics. Currently, the Immunohistochemistry market growth is being propelled by the rapid development of companion diagnostics and the global push for early-stage cancer screening. Unlike traditional staining, these advanced assays allow for the precise localization of proteins,...
0 Comments 0 Shares 5 Views 0 Reviews